BJDX

Bluejay Diagnostics, Inc.

3.48

Top Statistics
Market Cap 1 M Forward PE -10.88 Revenue Growth 0.00 %
Current Ratio 4.38 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.8050 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 8 M Total Cash Per Share 1.29 Total Debt 442134
Total Debt To Equity 5.12 Current Ratio 4.38 Book Value Per Share 18.69
All Measures
Short Ratio 9.00 % Message Board Id finmb_384143134 Shares Short Prior Month 97684
Return On Equity -1.25 City Acton Uuid 74bd969a-9ba0-37a6-9244-8da1cdf9cf23
Previous Close 3.62 First Trade Date Epoch Utc 1 B Book Value 18.69
Beta 0.7280 Total Debt 442134 Volume 19493
Price To Book 0.1862 Last Split Date 1 B Fifty Two Week Low 3.03
Total Cash Per Share 1.29 Shares Short Previous Month Date 1 B Max Age 86400
Sand P52 Week Change 0.3133 Net Income To Common -9404585 Short Percent Of Float 0.0097
Implied Shares Outstanding 552854 Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 115747 Average Volume10days 115747 Total Cash 8 M
Next Fiscal Year End 1 B Held Percent Insiders 0.0115 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 3.62
Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000 Fifty Day Average 5.27
Open 3.62 Free Cashflow -5485828 State MA
Dividend Yield 0.00 % Return On Assets -0.5851 Time Zone Short Name EST
Trailing Eps -804.00 Day Low 3.22 Address1 360 Massachusetts Avenue
Shares Outstanding 552854 Price Hint 4 Target High Price 0.0000
Website https://bluejaydx.com 52 Week Change -0.9973 Average Volume 339065
Forward Eps -0.3200 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 391.80 % Last Split Factor 1:50 Regular Market Day High 3.65
Is_sp_500 False Profit Margins 0.00 % Debt To Equity 5.12
Fifty Two Week High 1564.00 Day High 3.65 Shares Short 159885
Regular Market Open 3.62 Industry Key medical-devices Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.0097 Operating Cashflow -8052225
Currency USD Time Zone Full Name America/New_York Market Cap 1 M
Is_nasdaq_100 False Zip 01720 Quote Type EQUITY
Industry Medical Devices Long Name Bluejay Diagnostics, Inc. Regular Market Day Low 3.22
Held Percent Institutions 0.0095 Current Price 3.48 Address2 Suite 203
Enterprise To Ebitda 0.8050 Financial Currency USD Current Ratio 4.38
Industry Disp Medical Devices Country United States Float Shares 6 M
Two Hundred Day Average 123.05 Enterprise Value -7037328 Forward PE -10.88
Regular Market Volume 19493 Ebitda -8737628 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha
Bluejay Diagnostics, Inc. operates as a medical diagnostics company.

The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.

It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis.

In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings.

Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform.

The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.